OMX Stockholm Pharmaceuticals a SX201030GI Indice
6979.69 SEK
{{ price }}
-0.042628%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
6979.69
-
6979.69 SEK
Nombre de composants
32
OMX Stockholm Pharmaceuticals a Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | +9.36% | |
|---|---|---|---|
| ATORX.ST | Alligator Bioscience AB (publ) | +5.18% | |
| XBRANE.ST | Xbrane Biopharma AB (publ) | +5.1% | |
| BIOA-B.ST | BioArctic AB (publ) | +4.96% | |
| ACE.ST | Ascelia Pharma AB (publ) | +3.61% |
Top 5 Perdants au Cours des Dernières 24 Heures
| VICO.ST | Vicore Pharma Holding AB (publ) | -7.38% | |
|---|---|---|---|
| ACTI.ST | Active Biotech AB (publ) | -6.09% | |
| BINV.ST | BioInvent International AB (publ) | -2.88% | |
| ISOFOL.ST | Isofol Medical AB (publ) | -2.85% | |
| SYNACT.ST | SynAct Pharma AB | -2.39% |
OMX Stockholm Pharmaceuticals a SX201030GI APERÇU FINANCIER ET COMMERCIAL
| OMX Stockholm Pharmaceuticals a Prix de l'Indice | 6979.69 SEK |
| Dernière clôture | N/A |
| Ouverture | N/A |
| Offre | N/A x N/A |
| Demande | N/A x N/A |
| Variation du jour | N/A |
| Plage sur 52 semaines | N/A |
| Volume | N/A |
| Volume moyen | N/A |
Informations de trading
OMX Stockholm Pharmaceuticals a Historique des prix de l'Indice
| Plus haut sur 52 semaines | N/A |
| Plus bas sur 52 semaines | N/A |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
SX201030GI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice OMX Stockholm Pharmaceuticals a
Quel est le cours actuel de l'Indice SX201030GI ?
Le prix de l'Indice OMX Stockholm Pharmaceuticals a SX201030GI aujourd'hui est de 6979.69 SEK.
Comment acheter l'Indice OMX Stockholm Pharmaceuticals a ?
Vous pouvez acheter l'indice SX201030GI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice OMX Stockholm Pharmaceuticals a ?
Le symbole boursier ou ticker de l'Indice OMX Stockholm Pharmaceuticals a est SX201030GI.
Combien de composants contient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a contient 32 composants.
À quel pays appartient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a fait référence à United States.
À quelle bourse appartient l'Indice OMX Stockholm Pharmaceuticals a ?
L'Indice OMX Stockholm Pharmaceuticals a fait référence à la bourse Nasdaq GIDS.
OMX Stockholm Pharmaceuticals a COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $309 30.16 USD |
+0.46
|
$106.13B 10.36B USD | $217.24K 21.21K USD | $305 29.77 USD | $309.8 30.24 USD | $106.13B 10.36B USD | 27.01 | $11.44 1.12 USD |
| Camurus AB (publ) CAMX.ST | $537.5 52.47 USD |
-0.46
|
$31.65B 3.09B USD | $129.48K 12.64K USD | $532.5 51.98 USD | $552.5 53.93 USD | $31.65B 3.09B USD | 74.86 | $7.18 0.7 USD |
| Bonesupport Holding AB (publ) BONEX.ST | $279.2 27.25 USD |
-2.1
|
$18.39B 1.79B USD | $98.84K 9.65K USD | $276 26.94 USD | $283 27.62 USD | $18.39B 1.79B USD | 150.91 | $1.85 0.18 USD |
| BioArctic AB (publ) BIOA-B.ST | $184 17.96 USD |
+4.96
|
$16.29B 1.59B USD | $547.69K 53.46K USD | $177 17.28 USD | $186.6 18.21 USD | $16.29B 1.59B USD | 0 | -$2 -0.1 USD |
| Biotage AB (publ) BIOT.ST | $141.8 13.84 USD |
-0.14
|
$11.35B 1.11B USD | $1.43M 139.77K USD | $141.7 13.83 USD | $142.2 13.88 USD | $11.35B 1.11B USD | 44.59 | $3.18 0.31 USD |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD |
| BioGaia AB (publ) BIOG-B.ST | $106.4 10.39 USD |
+0.66
|
$10.76B 1.05B USD | $199.09K 19.43K USD | $104.5 10.2 USD | $106.8 10.43 USD | $10.76B 1.05B USD | 34.88 | $3.05 0.3 USD |
| MedCap AB (publ) MCAP.ST | $444 43.34 USD |
-1
|
$6.65B 649.29M USD | $10.19K 994.28 USD | $444 43.34 USD | $451.5 44.07 USD | $6.65B 649.29M USD | 32.67 | $13.59 1.33 USD |
| Probi AB (publ) PROB.ST | $348 33.97 USD |
0
|
$3.97B 387.05M USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97B 387.05M USD | 0 | $0 0 USD |
| BioInvent International AB (publ) BINV.ST | $30.4 2.97 USD |
-2.88
|
$2B 195.27M USD | $59.98K 5.85K USD | $30.15 2.94 USD | $31.3 3.06 USD | $2B 195.27M USD | 0 | -$7.12 -0.6 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $7.91 0.77 USD |
-7.38
|
$1.86B 181.12M USD | $425.29K 41.51K USD | $7.8 0.76 USD | $8.55 0.83 USD | $1.86B 181.12M USD | 0 | -$1.99 -0.1 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $24.46 2.39 USD |
+2.34
|
$1.6B 156.65M USD | $156.94K 15.32K USD | $23.8 2.32 USD | $24.72 2.41 USD | $1.6B 156.65M USD | 0 | -$9.25 -0.9 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $3.24 0.32 USD |
-0.61
|
$1.16B 113.44M USD | $718.8K 70.16K USD | $3.22 0.31 USD | $3.38 0.33 USD | $1.16B 113.44M USD | 0 | -$1 -0.09 USD |
| Saniona AB (publ) SANION.ST | $8.37 0.82 USD |
-0.83
|
$1.14B 111.19M USD | $298.47K 29.13K USD | $8.24 0.8 USD | $8.47 0.83 USD | $1.14B 111.19M USD | 4.75 | $1.76 0.17 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $30.5 2.98 USD |
-1.61
|
$1.13B 110.57M USD | $12.43K 1.21K USD | $30 2.93 USD | $33.45 3.27 USD | $1.13B 110.57M USD | 0 | -$7.59 -0.7 USD |
| SynAct Pharma AB SYNACT.ST | $17.96 1.75 USD |
-2.39
|
$880.2M 85.92M USD | $257.47K 25.13K USD | $17.46 1.7 USD | $18.22 1.78 USD | $880.2M 85.92M USD | 0 | -$2.08 -0.2 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $61.9 6.04 USD |
+9.36
|
$833.88M 81.4M USD | $9.25K 902.62 USD | $57 5.56 USD | $61.9 6.04 USD | $833.88M 81.4M USD | 0 | -$9.34 -0.9 USD |
| Abliva AB (publ) ABLI.ST | $0.44 0.04 USD |
0
|
$715.67M 69.86M USD | $0 0 USD | $0 0 USD | $0 0 USD | $715.67M 69.86M USD | 0 | $0 0 USD |
| Orexo AB (publ) ORX.ST | $13.8 1.35 USD |
0
|
$476.17M 46.48M USD | $4.66K 455.17 USD | $13.6 1.33 USD | $13.98 1.36 USD | $476.17M 46.48M USD | 0 | -$6.09 -0.5 USD |
| Oncopeptides AB (publ) ONCO.ST | $2 0.2 USD |
-0.1
|
$422.11M 41.2M USD | $204.61K 19.97K USD | $1.97 0.19 USD | $2.03 0.2 USD | $422.11M 41.2M USD | 0 | -$1.71 -0.1 USD |
- {{ link.label }} {{link}}